Biomarker, Innovation, Research
May 14, 2021
Via: MedPageTodayAn investigational antibody-drug conjugate (ADC) achieved disease control in all but one patient with advanced or metastatic triple-negative breast cancer, results of a preliminary clinical study showed. Nine of 21 evaluable patients had objective responses and 11 had stable disease […]